secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tectonic Therapeutic, Inc. (TECX)
CIK:        0001681087
Form:       8-K
Filed at:   2024-06-20T23:59:59+00:00
Accession:  0001193125-24-164480
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 2.01, 1.01, 9.01, 5.02, 4.01, 2.02, 3.02, 3.03, 5.01, 5.03, 5.06, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tectonic Therapeutic completes merger with AVROBIO, begins trading as TECX
--------------------------------------------------------------------------

- Merger completed on June 20, 2024; AVROBIO merged into Tectonic, which survived as a wholly owned subsidiary.
- AVROBIO effected a 1-for-12 reverse stock split and changed its name to Tectonic Therapeutic, Inc.
- Shares began trading on Nasdaq under ticker TECX on June 21, 2024, replacing prior symbol AVRO.
- Contingent Value Rights (CVRs) issued to AVROBIO stockholders for potential proceeds from legacy assets.
- Post-merger ownership: Tectonic securityholders ~75.2%, AVROBIO securityholders ~24.8% on a diluted basis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681087/000119312524164480/0001193125-24-164480-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681087/000119312524164480/d852858d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-164480

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer